Course overview:

Bone Turnover Markers (BTM) have long been used as diagnostic tests for metabolic bone diseases. In the past 20 years, markers that are more specific to bone have been introduced and have been found to be useful in osteoporosis, particularly for monitoring treatment. This course aims to provide a background to the clinical use of bone turnover markers.

Target audience:

This day-long course is open to clinicians (e.g. endocrinology, rheumatology, care of the elderly and clinical chemistry), laboratory scientists and nurses involved in the clinical management of patients at risk of osteoporotic fractures.

Objectives:

At the end of the course, participants should:

  • understand the process of bone remodelling and how this can be studied using BTM
  • appreciate the methods used for measuring BTM and their sources of variability
  • be able to identify the role of BTM in the diagnosis and monitoring of bone diseases in a number of clinical settings including; osteoporosis, chronic kidney disease, Paget’s disease, osteomalacia, and GIOP,.
  • be familiar with best practice in the clinical use of BTM

 

PRE-CONGRESS PROGRAMME

Friday 15 May 2020
Marseille Chanot, Palais des Arts, Marseille, France

Training Co-Chairs: Richard Eastell, Sheffield, UK; Pawel Szulc, Lyon, France

 

11:00 – 11:25Registrations
11.25 – 11.30BONE TURNOVER MARKERS: AN INTRODUCTIONRichard Eastell (Sheffield, UK)
11.30 – 12.00BONE REMODELLING AND THE INTERPRETATION OF BONE TURNOVER MARKER (BTM) RESULTS Richard Eastell (Sheffield, UK)
12.00– 12.30PRACTICAL ASPECTS OF MEASUREMENT AND SELECTION OF MARKERPawel Szulc (Lyon, France)
12.30 – 13.00SOURCES OF VARIABILITY IN BTM Nuria Guanabens (Barcelona, Spain)
13.00 – 14.00Lunch Break
14.00 – 14.30USE OF BTM IN OSTEOPOROSIS: SHARED CARE PROTOCOLS IN PRIMARY CARE Jennie Walsh (Sheffield, UK)
14.30 – 15.30Interactive Workshops GROUP A & GROUP B
GROUP A: PROTOCOLS AND CASE EXAMPLES FOR THE USE OF BTM IN OSTEOPOROSIS PRACTICE
Jennie Walsh (Sheffield, UK), Nuria Guanabens (Barcelona, Spain)
GROUP B: USING BTM FOR OSTEOPOROSIS TREATMENT: RESEARCH APPLICATION
 Richard Eastell (Sheffield, UK), Pawel Szulc (Lyon, France)
15:30-16.00METABOLIC BONE DISEASES IN ADULTS Eugene McCloskey (Sheffield, UK)
16.00 – 16.30Coffee break
16.30 – 17.00METABOLIC BONE DISEASE OF CHRONIC KIDNEY DISORDERSpeaker to be announced
17.00 – 18.00Interactive Workshops GROUP A & GROUP B
GROUP A: PROTOCOLS FOR THE USE OF BTM IN OSTEOPOROSIS PRACTICE
Jennie Walsh (Sheffield, UK), Nuria Guanabens (Barcelona, Spain) 
GROUP C: USING BTM IN METABOLIC BONE DISEASE
Eugene McCloskey (Sheffield, UK) Jaja Salam (Sheffield, UK) 
18.00 – 18.30EXPERT PANEL: QUESTIONS AND ANSWERS All speakers
18.30Close of the Training